Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
Peter Kraemer, Ph.D.
Peter Kraemer, Ph.D. ([email protected]), is responsible for directing technical projects, chemistry and biotech development, and large-scale fermentation at Sanofi.
More GEN Content From This Contributor
- Tutorials: Stainless Steel Nowhere Near Over the Hill